NIKA PHARMACEUTICALS, INC. Deferred Tax Assets, Operating Loss Carryforwards
NIKA PHARMACEUTICALS, INC. (NIKA) had Deferred Tax Assets, Operating Loss Carryforwards of $1.89 million as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-25
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.89M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.88M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $714.00K.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $700.00K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $1.89M 10-K · filed 2026-03-25 | |
| 2024-12-31 | $1.88M 10-K · filed 2026-03-25 | |
| 2023-12-31 | $714.00K 10-K · filed 2025-03-31 | |
| 2022-12-31 | $700.00K 10-K · filed 2024-04-01 | |
| 2021-12-31 | $31.86K 10-K · filed 2023-04-10 | |
| 2020-12-31 | $28.77K 10-K · filed 2022-03-03 | -$28.77K 10-K · filed 2021-03-24 |
| 2019-12-31 | -$26.90K 10-K · filed 2021-03-24 |